{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:23:47Z","timestamp":1792034627211,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacc.2025.08.046","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T07:20:22Z","timestamp":1756624822000},"page":"1843-1857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-8533","authenticated-orcid":false,"given":"Subodh","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei-Mircea","family":"Catarig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Houlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Ludvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Nordanstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Rasouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidse K.","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-3584","authenticated-orcid":false,"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.08.046_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.08.046_bib2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s13300-024-01606-6","article-title":"Epidemiology and burden of peripheral artery disease in people with type 2 diabetes: a systematic literature review","volume":"15","author":"Verma","year":"2024","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jacc.2025.08.046_bib3","first-page":"560","article-title":"Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease","volume":"38","author":"Abramson","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib4","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.9778\/cmajo.20200048","article-title":"Regional health care services and rates of lower extremity amputation related to diabetes and peripheral artery disease: an ecological study","volume":"8","author":"de Mestral","year":"2020","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jacc.2025.08.046_bib5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.121.320702","article-title":"Sex differences in peripheral artery disease","volume":"130","author":"Pabon","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.08.046_bib7","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.1161\/CIR.0000000000001310","article-title":"Sex differences in peripheral vascular disease: a scientific statement from the American Heart Association","volume":"151","author":"Kim","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.046_bib8","doi-asserted-by":"crossref","first-page":"E124","DOI":"10.9778\/cmajo.20150107","article-title":"Sex differences in the outcomes of peripheral arterial disease: a population-based cohort study","volume":"4","author":"Hussain","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jacc.2025.08.046_bib9","first-page":"356","article-title":"Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations, and outcomes","volume":"34","author":"Srivaratharajah","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jvs.2006.10.032","article-title":"Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"45","author":"Aboyans","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.08.046_bib11","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacc.2025.08.046_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-020-01130-4","article-title":"Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis","volume":"19","author":"Chase-Vilchez","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2025.08.046_bib13","article-title":"Sex differences in risk factors for incident peripheral artery disease hospitalisation or death: cohort study of UK Biobank participants","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.046_bib14","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.046_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1532-5415.2003.51061.x","article-title":"Sex differences in peripheral arterial disease: leg symptoms and physical functioning","volume":"51","author":"McDermott","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacc.2025.08.046_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jacc.2010.09.042","article-title":"Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease","volume":"57","author":"McDermott","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/2047487314520783","article-title":"Sex bias in referral of women to outpatient cardiac rehabilitation? A meta-analysis","volume":"22","author":"Colella","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib18","first-page":"1316","article-title":"Sex differences in cardiac rehabilitation adherence: a meta-analysis","volume":"32","author":"Oosenbrug","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2003.11.061","article-title":"The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III","volume":"43","author":"Ford","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HCR.0000000000000343","article-title":"Exercise rehabilitation for peripheral artery disease: a review","volume":"38","author":"McDermott","year":"2018","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2025.08.046_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2008.962","article-title":"Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial","volume":"301","author":"McDermott","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.046_bib22","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.046_bib23","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0256-4947.83219","article-title":"Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital","volume":"31","author":"Al-Omran","year":"2011","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2006.02.024","article-title":"ACC\/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease","volume":"47","author":"Hirsch","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"10489","key":"10.1016\/j.jacc.2025.08.046_bib26","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.046_bib27","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jacc.2024.08.022","article-title":"Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT): outcomes by sex","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2025.08.046_bib28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jacc.2024.06.001","article-title":"Efficacy of semaglutide by sex in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF Trials","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ehjcvp\/pvae071","article-title":"Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes","volume":"10","author":"Bonaca","year":"2025","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2025.08.046_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2025.08.046_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jvs.2015.03.076","article-title":"Gender differences following supervised exercise therapy in patients with intermittent claudication","volume":"62","author":"Gommans","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.08.046_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/jwh.2018.7113","article-title":"Gender differences in outcomes following a pain-free, home-based exercise program for claudication","volume":"28","author":"Manfredini","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jacc.2025.08.046_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jvs.2013.10.058","article-title":"Diabetic women are poor responders to exercise rehabilitation in the treatment of claudication","volume":"59","author":"Gardner","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.08.046_bib34","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/2047487319893046","article-title":"Myocardial infarction and peripheral arterial disease: treatment patterns and long-term outcome in men and women results from a Swedish nationwide study","volume":"28","author":"Sigvant","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jvs.2020.03.052","article-title":"Meaningful change in 6-minute walk in people with peripheral artery disease","volume":"73","author":"McDermott","year":"2021","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.08.046_bib37","series-title":"Patient-focused drug development guidance public workshop. Methods to identify what is important to patients & select, develop and modify fit-for-purpose clinical outcome assessments","year":"2018"},{"key":"10.1016\/j.jacc.2025.08.046_bib38","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.08.046_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"Allison","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.ATV.18.2.185","article-title":"Peripheral arterial disease in the elderly: the Rotterdam Study","volume":"18","author":"Meijer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2025.08.046_bib41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/eurjpc\/zwaa031","article-title":"Sex steroids and markers of micro- and macrovascular damage among women and men from the general population","volume":"29","author":"Aribas","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1358863X08101018","article-title":"Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease","volume":"14","author":"Payvandi","year":"2009","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1024\/0301-1526\/a000544","article-title":"Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease","volume":"45","author":"Buschmann","year":"2016","journal-title":"Vasa"},{"issue":"38","key":"10.1016\/j.jacc.2025.08.046_bib44","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","article-title":"Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement","volume":"46","author":"Romeo","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.046_bib45","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF Program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2025.08.046_bib47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/HCO.0000000000000562","article-title":"Glucagon-like peptide-1 receptor agonists and cardiovascular protection in type 2 diabetes: a pathophysiology-based review of clinical implications","volume":"33","author":"Bajaj","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib48","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/eurheartj\/ehae744","article-title":"Pump, pipes, filter, sugar, weight, and more: the pluripotent prowess of semaglutide","volume":"46","author":"Verma","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.046_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101597","article-title":"Generalizability of SELECT to cardiac surgical patients: analysis of the TRICS III randomized trial","volume":"4","author":"Dhingra","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacc.2025.08.046_bib50","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.046_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2024.04.022","article-title":"Semaglutide and NT-proBNP in obesity-related HFpEF: insights from the STEP-HFpEF Program","volume":"84","author":"Petrie","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11886-023-02016-z","article-title":"Worth their weight? An update on new and emerging pharmacologic agents for obesity and their potential role for persons with cardiac conditions","volume":"26","author":"Harrington","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2025.08.046_bib54","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1093\/eurheartj\/ehad664","article-title":"The cardiovascular effects of novel weight loss therapies","volume":"44","author":"Usman","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.046_bib55","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1093\/eurheartj\/ehad445","article-title":"Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table","volume":"44","author":"Cosentino","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.046_bib56","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.046_bib57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dom.14890","article-title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses","volume":"25","author":"Kosiborod","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2025.08.046_bib58","first-page":"1153","article-title":"2022 Canadian Cardiovascular Society guideline for use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal risk reduction in adults","volume":"38","author":"Mancini","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib59","doi-asserted-by":"crossref","first-page":"H370","DOI":"10.1152\/ajpheart.00257.2024","article-title":"GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes","volume":"327","author":"Park","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib60","doi-asserted-by":"crossref","first-page":"H1159","DOI":"10.1152\/ajpheart.00574.2023","article-title":"GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage","volume":"326","author":"Park","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib61","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/cvr\/cvae016","article-title":"Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity","volume":"119","author":"Terenzi","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.08.046_bib62","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jacc.2023.12.012","article-title":"Vascular regenerative cell deficiencies in South Asian adults","volume":"83","author":"Krishnaraj","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.046_bib63","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/eurheartj\/ehab758","article-title":"Vascular repair and regeneration in cardiometabolic diseases","volume":"43","author":"Hess","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.046_bib64","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11154-021-09669-7","article-title":"Lessons from bariatric surgery: can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?","volume":"22","author":"Bakbak","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jacc.2025.08.046_bib65","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molmed.2019.03.006","article-title":"Vascular regenerative cell exhaustion in diabetes: translational opportunities to mitigate cardiometabolic risk","volume":"25","author":"Terenzi","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacbts.2018.10.005","article-title":"Circulating pro-vascular progenitor cell depletion during type 2 diabetes: translational insights into the prevention of ischemic complications in diabetes","volume":"4","author":"Terenzi","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacc.2025.08.046_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/stem.2751","article-title":"Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies","volume":"36","author":"Qadura","year":"2018","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.jacc.2025.08.046_bib68","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc25-1082","article-title":"Benefit of semaglutide in symptomatic peripheral artery disease by baseline type 2 diabetes characteristics: insights from STRIDE, a randomized, placebo-controlled, double-blind trial","volume":"48","author":"Rasouli","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.046_bib69","first-page":"2090","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"383","author":"Bonaca","year":"2020","journal-title":"Reply. N Engl J Med"},{"issue":"20","key":"10.1016\/j.jacc.2025.08.046_bib70","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.046_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib72","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib73","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib74","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jacc.2025.08.046_bib75","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib76","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.046_bib77","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/dom.14700","article-title":"Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease","volume":"24","author":"Verma","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2025.08.046_bib78","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.118.033898","article-title":"Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease: results of the LEADER Trial","volume":"137","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.046_bib79","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cmet.2025.05.001","article-title":"GLP-1RAs for peripheral artery disease: a remarkable STRIDE in the right direction","volume":"37","author":"Verma","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacc.2025.08.046_bib80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mva.2001.112326","article-title":"Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia","volume":"33","author":"Morgan","year":"2001","journal-title":"J Vasc Surg"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725075540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725075540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:24:47Z","timestamp":1766193887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725075540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":80,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0735109725075540"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.046","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}